Table 1. Differences in chemotherapeutic drug IC₅₀s in non-selected and doxorubicin-selected FL/ΔAkt-1:ER*(Myr⁺) + ΔRaf-1:AR cells¹.

Cell line→	Non-selected	Doxorubicin-selected	Fold difference
Drug↓
Doxorubicin	25 ± 6 nM	65 ± 11 nM	2.6X
Daunorubicin	9 ± 3 nM	18 ± 5 nM	2.0X
Paclitaxel	3 ± 0.8 nM	13 ± 2 nM	4.3X
Cisplatin	80,000 ± 9,000	90,000 ± 11,000 nM	1.1X
5-Flurouracil	1,000 ± 200 nM	1,200 ± 100 nM	1.2X

¹ Determined by plating 2,500 cells/well in 96 well plates in 500 nM 4HT + 100 nM as described in materials and methods.